DiaMedica Therapeutics Inc. (DMAC) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts DMAC Hot Sheet
Join SI Premium – FREE
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) reported Q3 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).
For earnings history and earnings-related data on DiaMedica Therapeutics Inc. (DMAC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- GE Vernova (GEV) PT Raised to $1,185 at Jefferies
- UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
